Insufficient scRNA-seq data for expression of PLA2G4B at single-cell level.
Insufficient scRNA-seq data for expression of PLA2G4B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 4193.09 | 170 / 170 | 10% | 0.17 | 48 / 459 |
lung | 99% | 3282.99 | 575 / 578 | 6% | 0.10 | 69 / 1155 |
bladder | 100% | 3378.00 | 21 / 21 | 5% | 0.08 | 27 / 504 |
esophagus | 99% | 3978.07 | 1431 / 1445 | 4% | 0.07 | 8 / 183 |
thymus | 100% | 6859.14 | 653 / 653 | 2% | 0.03 | 11 / 605 |
prostate | 100% | 6812.82 | 244 / 245 | 2% | 0.02 | 9 / 502 |
breast | 100% | 3112.39 | 458 / 459 | 1% | 0.01 | 11 / 1118 |
ovary | 100% | 5705.88 | 180 / 180 | 0% | 0.01 | 2 / 430 |
spleen | 100% | 3903.99 | 241 / 241 | 0% | 0 | 0 / 0 |
intestine | 100% | 2595.01 | 963 / 966 | 0% | 0.00 | 1 / 527 |
kidney | 99% | 2858.37 | 88 / 89 | 1% | 0.01 | 7 / 901 |
pancreas | 99% | 2216.67 | 326 / 328 | 0% | 0 | 0 / 178 |
stomach | 98% | 2085.44 | 353 / 359 | 0% | 0 | 0 / 286 |
adipose | 97% | 2218.33 | 1169 / 1204 | 0% | 0 | 0 / 0 |
brain | 92% | 4644.63 | 2418 / 2642 | 3% | 0.05 | 23 / 705 |
liver | 94% | 1780.55 | 212 / 226 | 0% | 0 | 0 / 406 |
blood vessel | 94% | 1793.21 | 1252 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 88% | 1532.45 | 227 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 79% | 1446.10 | 731 / 929 | 0% | 0 | 0 / 0 |
heart | 76% | 1240.52 | 655 / 861 | 0% | 0 | 0 / 0 |
skin | 73% | 7009.24 | 1318 / 1809 | 0% | 0.00 | 1 / 472 |
muscle | 39% | 506.79 | 314 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.07 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0036148 | Biological process | phosphatidylglycerol acyl-chain remodeling |
GO_0006954 | Biological process | inflammatory response |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_0007567 | Biological process | parturition |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0102545 | Molecular function | phosphatidyl phospholipase B activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
Gene name | PLA2G4B |
Protein name | Phospholipase A2 group IVB Cytosolic phospholipase A2 beta (cPLA2-beta) (EC 3.1.1.4) (Lysophospholipase A1 group IVB) (EC 3.1.1.5) (Phospholipase A2 group IVB) |
Synonyms | |
Description | FUNCTION: Calcium-dependent phospholipase A1 and A2 and lysophospholipase that may play a role in membrane phospholipid remodeling. .; FUNCTION: [Isoform 3]: Calcium-dependent phospholipase A2 and lysophospholipase. Cleaves the ester bond of the fatty acyl group attached to the sn-2 position of phosphatidylethanolamines, producing lysophospholipids that may be used in deacylation-reacylation cycles. Hydrolyzes lysophosphatidylcholines with low efficiency but is inefficient toward phosphatidylcholines. .; FUNCTION: [Isoform 5]: Calcium-dependent phospholipase A1 and A2 and lysophospholipase. Cleaves the ester bond of the fatty acyl group attached to the sn-1 or sn-2 position of diacyl phospholipids (phospholipase A1 and A2 activity, respectively), producing lysophospholipids that may be used in deacylation-reacylation cycles. Can further hydrolyze lysophospholipids enabling complete deacylation. Has no activity toward alkylacyl phospholipids. . |
Accessions | H3BSX5 P0C869 ENST00000569354.1 ENST00000458483.4 [P0C869-1] ENST00000452633.5 [P0C869-1] |